Title |
Antibiotic Treatment of Constipation-Predominant Irritable Bowel Syndrome
|
---|---|
Published in |
Digestive Diseases and Sciences, May 2014
|
DOI | 10.1007/s10620-014-3157-8 |
Pubmed ID | |
Authors |
Mark Pimentel, Christopher Chang, Kathleen Shari Chua, James Mirocha, John DiBaise, Satish Rao, Meridythe Amichai |
Abstract |
The antibiotic rifaximin is used to treat non-constipated irritable bowel syndrome (IBS). Methane production is associated with constipation and its severity in constipation-predominant IBS (C-IBS). A previous retrospective study suggested that rifaximin and neomycin was superior to neomycin alone in improving symptoms in methane-positive subjects. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 57% |
United Kingdom | 1 | 14% |
Unknown | 2 | 29% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 71% |
Scientists | 1 | 14% |
Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 1% |
Unknown | 94 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 15 | 16% |
Researcher | 13 | 14% |
Student > Master | 11 | 12% |
Other | 9 | 9% |
Student > Ph. D. Student | 7 | 7% |
Other | 18 | 19% |
Unknown | 22 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 34 | 36% |
Agricultural and Biological Sciences | 6 | 6% |
Nursing and Health Professions | 5 | 5% |
Social Sciences | 4 | 4% |
Biochemistry, Genetics and Molecular Biology | 3 | 3% |
Other | 12 | 13% |
Unknown | 31 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2022.
All research outputs
#4,225,990
of 23,854,458 outputs
Outputs from Digestive Diseases and Sciences
#575
of 4,304 outputs
Outputs of similar age
#40,477
of 230,935 outputs
Outputs of similar age from Digestive Diseases and Sciences
#7
of 57 outputs
Altmetric has tracked 23,854,458 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,304 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 230,935 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.